Pembrolizumab re-challenge in patients with relapsed non-small cell lung cancer (NSCLC): A preliminary report of the REPLAY phase II trial - cohort I

Autor: Aix, SP, Costa, EC, Bosch-Barrera, J, Font, EF, Guirado, M, Sarto, JC, Tarruella, MM, Vidal, OJJ, Portulas, ED, Diz, P, Granados, ALOO, Gomez, MD, Cordellat, AB, Martinez, JM, Gonzalez, MAS, Dorta, M, de Juan, VC, Zugazagoitia, J, Enguita, AB, Paz-Ares, L

Publikováno v: Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::496e8d1f26edb933e9cbb00045e7754e
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1475

Effect of central nervous system (CNS) metastases in a real-world multicenter cohort study of Spanish ALK-positive non-small cell lung cancer (NSCLC) patients (p)

Autor: Angelats, L, Campelo, MRG, Caro, RB, Aperribay, EA, de Juan, VC, Joaquin, AB, Segarra, NV, Moreno, MDLLG, Martinez, LV, Vidal, OJJ, Quintela, NV, Cobo, M, Sais, E, Gomez, MD, Nunez, NF, Sarto, JC, Fabregat, RM, Gomez, AME, Rodriguez-Abreu, D, Costa, EC

Publikováno v: Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::b72acd0a87ced0edbe720de60a5f68bb
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3957

JNJ-64041757 (JNJ-757), a Live, Attenuated, Double-Deleted Listeria monocytogenes -Based Immunotherapy in Patients With NSCLC: Results From Two Phase 1 Studies.

Autor: Brahmer JR; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland., Johnson ML; Lung Cancer Research and Drug Development, Sarah Cannon Research Institute, Nashville, Tennessee., Cobo M; Unidad de Gestión Clínica Intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga, Málaga, Spain., Viteri S; Dr. Rosell Oncology Institute, Dexeus University Hospital, Quironsalud Group, Barcelona, Spain., Sarto JC; Department of Medical Oncology, Hospital Son Llatzer, Palma de Mallorca, Spain., Sukari A; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Awad MM; Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts., Salgia R; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, California., Papadimitrakopoulou VA; Department of Medical Oncology, The University of Texas MD Anderson, Houston, Texas., Rajan A; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Bandyopadhyay N; Janssen Research and Development, Spring House, Pennsylvania., Allred AJ; Janssen Research and Development, Spring House, Pennsylvania., Wade M; Janssen Research and Development, Spring House, Pennsylvania., Mason GE; Janssen Research and Development, Spring House, Pennsylvania., Zudaire E; Janssen Research and Development, Spring House, Pennsylvania., Knoblauch RE; Janssen Research and Development, Spring House, Pennsylvania., Stone N; Janssen Research and Development, Spring House, Pennsylvania., Lorenzi MV; Janssen Research and Development, Spring House, Pennsylvania., Hassan R; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Publikováno v: JTO clinical and research reports [JTO Clin Res Rep] 2020 Oct 05; Vol. 2 (2), pp. 100103. Date of Electronic Publication: 2020 Oct 05 (Print Publication: 2021).

T-Cell Responses to Immunodominant Listeria Epitopes Limit Vaccine-Directed Responses to the Colorectal Cancer Antigen, Guanylyl Cyclase C.

Autor: Flickinger Jr, John C., Singh, Jagmohan, Yarman, Yanki, Carlson, Robert D., Barton, Joshua R., Waldman, Scott A., Snook, Adam E.

Publikováno v: Frontiers in Immunology; 3/9/2022, Vol. 13, p1-11, 11p

Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer.

Autor: Drake CG; Columbia University Medical Center, New York, NY, USA. cdrake2@its.jnj.com.; Janssen Research & Development, Spring House, PA, USA. cdrake2@its.jnj.com., Pachynski RK; Washington University of St. Louis, St. Louis, MO, USA., Subudhi SK; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McNeel DG; University of Wisconsin Carbone Cancer Center, Madison, WI, USA., Antonarakis ES; Johns Hopkins Kimmel Medical Institute, Baltimore, MD, USA., Bauer TM; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA., Lauer P; Aduro Biotech, Berkeley, CA, USA., Brockstedt D; Aduro Biotech, Berkeley, CA, USA., Patricia D; Janssen Research & Development, Spring House, PA, USA., Wade M; Janssen Research & Development, Spring House, PA, USA., Zudaire E; Janssen Research & Development, Spring House, PA, USA., Bandyopadhyay N; Janssen Research & Development, Raritan, NJ, USA., Parasrampuria DA; Janssen Research & Development, Spring House, PA, USA., Girgis S; Janssen Research & Development, Spring House, PA, USA., Mason GE; Janssen Research & Development, Spring House, PA, USA., Knoblauch RE; Janssen Research & Development, Spring House, PA, USA., Stone N; Janssen Research & Development, Spring House, PA, USA., Infante JR; Janssen Research & Development, Spring House, PA, USA., Gottardis MM; Janssen Research & Development, Spring House, PA, USA., Fong L; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2022 Feb; Vol. 25 (2), pp. 219-228. Date of Electronic Publication: 2021 Jul 13.